Forbes April 29, 2024
William A. Haseltine

This article joins a growing series on mono cancer treatments, including novel immunotherapies such as CAR T therapy and checkpoint inhibitors.

Cutting-edge technologies have transformed the way we treat cancers. While chemotherapy and other traditional treatments directly interfere with cancer cells, immunotherapies born in recent decades empower the body’s inherent ability to counter tumors. Checkpoint inhibitors join this refreshing charge. This novel anticancer medicine can renew the immune system’s ability to detect and attack cancer cells. By the same token, this mechanism can spark unwanted effects. To understand how this therapy works, let’s explore the immune system’s natural functions.

Achieving Immune Balance

The immune system protects and regulates the body. This intricate network of cells, tissues and organs defends the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Provider
Wegovy could bankrupt US health system, Sanders says in new report
Uniquity Bio emerges with $300m for MSD immunology drug
Merck takes a slim lead in oncologists' perceptions amid a 'fiercely competitive' environment
Leqembi gets closer to being offered as an injection
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170

Share This Article